Fraunhofer-Gesellschaft
Fraunhofer-Gesellschaft

Partners

Fraunhofer Institute for Toxicology and Experimental Medicine ITEM

Protecting man from health hazards and contributing to the development of novel therapeutic approaches are the aims Fraunhofer ITEM is pursuing with its research. Our focuses are on cardiovascular and lung research, drug development, biomedical engineering, chemical safety and bioinformatics.

A focus in our Division of Translational Biomedical Engineering is on the development of additively manufactured, active implants using medical-grade silicone, including safety testing. This is complemented by the (bio-)pharmaceutical improvement of implants and functional (long-term) in vivo testing of neurological and other electrophysiological implants (e.g. cardiac pacemakers) as well as of passive implants such as finger joint and hip implants.

Furthermore, (GMP) manufacturing of (bio)pharmaceutical active ingredients – also for formulations for inhaled administration and inhaler development – belongs to our core research activities. Regulatory research and risk assessment in the fields of medical device and drug development complement our portfolio.

 

Go to the website of Fraunhofer ITEM.

Fraunhofer Research Institution for Individualized and Cell-Based Medical Engineering IMTE

The focus of the Fraunhofer Research Institution for Individualized and Cell-Based Medical Engineering IMTE in Lübeck is in particular on the integrated development of medical devices for diagnostic and therapeutic applications. By combining competencies from medical engineering and cell technology, together with a strong connection to leading university hospitals and the close integration of regulatory aspects, Fraunhofer IMTE is able to offer a unique service portfolio to the medical device industry.

The holistic approach to research questions and projects in individualized medical technology at Fraunhofer IMTE, from basic research to medical device construction, paves the way for the translation of personalized instrumentation into clinical and commercial applications.

 

Go to the website of Fraunhofer IMTE

Fraunhofer Institute for Surface Engineering and Thin Films IST

Fraunhofer IST develops tailor-made and sustainable solutions, also taking into account closed material and substance cycles. Our portfolio scales from the development of prototypes through production scenarios to industrial dimensions.

Coating and surface technologies are key to innovative product systems, also for medical and pharmaceutical process engineering. In collaboration with partners at the Center for Pharmaceutical Process Engineering (PVZ) at Braunschweig University of Technology, pharmaceutical production technologies and product developments are being developed at different industrial scales for the production of individualized medicines, taking into account specific regulatory, plant-specific, infrastructural and corporate conditions.

 

Go to the website of Fraunhofer IST

Further partners

Hannover Medical School

The Hannover Medical School (MHH) is one of the most research-intensive medical universities in Germany. In its cooperation with the High-Performance Center Medical and Pharmaceutical Engineering, the focus is on biomedical engineering in the field of respiratory technologies and implant research. Both science and industry benefit from the integration model of the MHH, as research, education and clinical practice are closely intertwined.

Read more
 

© Fraunhofer ITEM, Ralf Mohr

University of Lübeck

Research and teaching at the University of Lübeck started in the medical field. Today, the scope of subjects, with computer and natural sciences and technology, goes far beyond, giving the university its focus on the life sciences under the motto: focus on life.

Read more

TH Lübeck

Lübeck University of Technology (TH Lübeck) has been holding the Chair of Regulatory Affairs in Biomedical Sciences since 2016. This interdisciplinary field is becoming increasingly important, as the requirements for approval and conformity assessment procedures for medical devices – including in vitro diagnostics – have been increasing significantly, not only in the EU but also at a global scale. The norms and standards are significant for the quality, safety and performance of medical devices throughout their life cycle. In cooperation with the University of Lübeck, the "Centre for Regulatory Affairs in Biomedical Sciences" at TH Lübeck addresses regulatory issues from all medical device areas as well as projects from related areas such as drug law, transfusion medicine and biosafety.

Read more
 

© diephotodesigner

NIFE

The Lower Saxony Center for Biomedical Engineering, Implant Research and Development (NIFE) in Hannover is among the leading locations for biomedical research and development. Its collaboration with Fraunhofer ITEM has a focus on transdisciplinary implant research and further development of additive manufacturing.

Read more

Leibniz University Hannover

Universality, interdisciplinarity and internationality are the strengths of the Leibniz University Hannover (LUH) towards outstanding research performance. Leibniz University and the Fraunhofer Institute for Toxicology and Experimental Medicine ITEM have established a cooperation specifically in the field of biomedical research. In the Translational Alliance in Lower Saxony (TRAIN), they are pooling their know-how and infrastructure together with other universities and non-university research institutions in order to accelerate the transfer of potential active agents and vaccines from bench to bedside.

Read more
 

© PVZ / TU Braunschweig, Karl-Falco Storm

Center of Pharmaceutical Engineering

The need to treat widespread diseases with innovative drugs is continuously increasing. All steps that accelerate the manufacturing process of drugs by means of new processes and technologies contribute to securing the pharmaceutical supply, while at the same time increasing cost-pressure in the health care system. At the Center of Pharmaceutical Engineering, scientists from the fields of pharmacy, process engineering, production engineering and microtechnology have pooled their expertise to investigate new technologies and processes for the cost-effective manufacturing of active ingredients and drugs. Part of the research strategy is patient-specific pharmacotherapy using miniaturized active ingredients and drug manufacturing facilities.

Read more
 

© PVZ / TU Braunschweig, Marisol Glasserman

Braunschweig University of Technology

TU Braunschweig has clustered its research activities in four research focus areas so as to provide significant contributions and meet major societal challenges – from low-noise and low-emission aircraft to active agents against infectious diseases and to personalized medicines. In the research focus areas "Infections and Active Agents", natural and engineering sciences as well as computer science are combined in the BRICS research center to enable powerful systems biology, while the Center of Pharmaceutical Engineering is dedicated to the production and processing of these new active ingredients to provide cost-effective and effective drugs.

Read more

BioMedTec Science Campus

Together with renowned companies in northern Germany, the University of Lübeck, TH Lübeck, Fraunhofer IMTE, Fraunhofer MEVIS as well as Leibniz Center Borstel and the University Hospital Schleswig-Holstein form the BioMedTec Science Campus and represent a regional focus in the Cluster Life Science North. The BioMedTec Science Campus covers a wide range of degree programs and research areas – also beyond biomedical engineering.

Please note that the below link will lead you to a landing page in German language.

Read more
 

© iStock, baytunc

University Hospital Schleswig-Holstein

The University Hospital Schleswig-Holstein (UKSH), one of the largest university medical centers in Europe, combines top international research with interdisciplinary patient care and training of future generations of physicians. The close proximity to the Lübeck campus and the close collaboration in research and development in the field of medical technology make the UKSH an important partner in the clinical application and evaluation of new technologies.

Read more

Contact

Ulrich Froriep

Contact Press / Media

Dr. Ulrich Froriep

Division Co-Director of Safety Assessment and Toxicology & Head of Department of Biomedical Engineering

Phone +49 511 5350-294

Kristina Lachmann

Contact Press / Media

Dr. Kristina Lachmann

Group Manager Medical Technology and Pharmaceutical Systems

Fraunhofer Institute for Surface Engineering and Thin Films IST

Thomas Friedrich

Contact Press / Media

Dr. Thomas Friedrich

Group Leader Additive Manufacturing

Fraunhofer Research Institution for Individualized and Cell-Based Medical Engineering IMTE